These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7449633)

  • 1. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of congestive cardiac failure with vasodilators (author's transl)].
    Hauf GF; Bubenheimer P; Lönne E; Roskamm H
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1607-12. PubMed ID: 7307999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
    Page A; Larnaudie B; Pic A; Videau P; Besse P
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1367-75. PubMed ID: 120154
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of severe chronic cardiac insufficiency with dihydralazine. Short-and median-term results].
    Morand P; Lavigne G; Masson D; Latour F; Alison D
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):268-75. PubMed ID: 114137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)].
    Wolf R; Beck OA; Habel F; Hochrein H
    Z Kardiol; 1977 Aug; 66(8):459-64. PubMed ID: 899150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
    Kuck KH; Hanrath P; Zehnke A; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1384-8. PubMed ID: 7449634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of dihydralazine in the treatment of chronic cardiac insufficiency].
    Morand P; Baudouy M; Camous JP; Gibelin P; Leborgne L
    Ann Med Interne (Paris); 1985; 136(3):266-71. PubMed ID: 4026112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasodilators in chronic heart insufficiency].
    Bucher HJ
    Schweiz Rundsch Med Prax; 1986 Jan; 75(4):61-3. PubMed ID: 3952406
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure.
    Jezek V; Jezková J; Michaljanic A; Niederle P; Feuereisl R
    Eur Heart J; 1990 Dec; 11(12):1059-64. PubMed ID: 2292252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short- and medium-term hemodynamic effects of prazosin in chronic refractory cardiac failure].
    Gillard C; Boland J; Calay G
    Arch Mal Coeur Vaiss; 1982 Apr; 75(4):469-77. PubMed ID: 6808956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
    Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute and chronic effects of dihydralazine in severe congestive heart failure at rest and during exercise (author's transl)].
    Reifart N; Bunge T; Kaltenbach M; Bussmann WD
    Z Kardiol; 1982 Jan; 71(2):75-81. PubMed ID: 6803467
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of prazosin in therapy-resistant chronic cardiac failure (author's transl)].
    Lemke R; Trompler A; Kaltenbach M; Bussmann WD
    Dtsch Med Wochenschr; 1979 Dec; 104(50):1769-73. PubMed ID: 510213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of vasodilator agents in circulatory insufficienty].
    Halawa B
    Wiad Lek; 1979 Nov; 32(22):1617-20. PubMed ID: 120075
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Z Kardiol; 1983; 72 Suppl 3():141-6. PubMed ID: 6666215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.